Update: 21.06.2022
Last week: 23 week 2022 (06.06.2022 - 12.06.2022)
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 140 352 | 3.2% | 5.8% | 0.2 | 27 807 040 | 1.6% | 5.3% | 0.2 | 0.1% |
| YTD | 5 780 918 | 53.2% | 6.1% | 1.3 | 1 143 064 164 | 82.6% | 5.8% | 1.6 | 20.8% |
| MAT | 15 276 946 | 67.2% | 6.8% | 2.1 | 2 807 532 928 | 98.1% | 6.3% | 2.2 | 17.1% |
| DEXALGIN | |||||||||
| WoW | 34 555 | -3.1% | 0.8% | -0.1 | 14 657 388 | -3.2% | 2.0% | -0.2 | 6.2% |
| YTD | 989 625 | 38.1% | 0.8% | 0.1 | 408 012 165 | 50.4% | 2.1% | 0.4 | 16.6% |
| MAT | 2 111 768 | 9.2% | 0.7% | 0 | 837 594 539 | 17.1% | 2.0% | 0.1 | 7.2% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 92 051 | 1.4% | 63.6% | -1.3 | 46 814 233 | 1.0% | 70.2% | -1.2 | 3.5% |
| YTD | 2 521 576 | 12.3% | 63.3% | -10.3 | 1 269 106 342 | 27.6% | 70.3% | -8.1 | 30.5% |
| MAT | 5 557 400 | 12.7% | 66.8% | -5.5 | 2 699 023 471 | 28.8% | 74.0% | -4.1 | 22.1% |
| ESPUMISAN BABY | |||||||||
| WoW | 27 147 | -6.6% | 48.2% | -2.2 | 16 965 978 | -6.9% | 58.6% | -2.1 | -2.3% |
| YTD | 743 295 | -1.7% | 47.7% | -3.4 | 455 996 617 | 4.5% | 59.0% | -5.9 | 5.3% |
| MAT | 1 650 500 | -6.2% | 48.5% | -0.9 | 991 372 808 | 3.0% | 60.4% | -1 | -4.5% |
| FASTUM | |||||||||
| WoW | 19 117 | 5.7% | 0.5% | 0 | 9 810 429 | 5.4% | 1.3% | 0 | 6.9% |
| YTD | 572 017 | -11.6% | 0.7% | -0.1 | 288 188 960 | -3.0% | 1.6% | -0.4 | 5.5% |
| MAT | 1 309 583 | -12.8% | 0.7% | -0.1 | 631 238 380 | -5.2% | 1.7% | -0.3 | 1.9% |
| IODOMARIN | |||||||||
| WoW | 52 604 | -15.4% | 6.2% | -1.3 | 10 439 092 | -15.9% | 9.4% | -1.9 | 1.7% |
| YTD | 1 331 360 | 9.0% | 7.1% | 0.6 | 251 845 627 | 10.1% | 9.2% | 0.1 | -0.3% |
| MAT | 3 256 225 | 18.5% | 8.1% | 1.8 | 605 965 546 | 18.5% | 10.9% | 2 | -7.4% |
| LIOTON | |||||||||
| WoW | 27 844 | 8.2% | 2.5% | 0 | 29 247 203 | 9.4% | 4.8% | 0.1 | 9.8% |
| YTD | 697 602 | -4.8% | 2.8% | -0.2 | 701 137 524 | 20.5% | 5.1% | -0.2 | 0.2% |
| MAT | 1 657 199 | -5.9% | 3.1% | -0.1 | 1 521 961 929 | 12.9% | 5.5% | -0.1 | -3.1% |
| MEZYM | |||||||||
| WoW | 348 317 | 5.8% | 28.0% | -0.2 | 52 383 535 | 4.9% | 19.4% | -0.4 | 6.6% |
| YTD | 10 514 556 | 31.3% | 29.9% | 4 | 1 608 160 649 | 42.2% | 21.5% | 1.9 | 13.7% |
| MAT | 23 266 753 | 27.0% | 30.8% | 4.1 | 3 385 540 095 | 32.5% | 22.5% | 1.9 | 10.2% |
| MIG 400 | |||||||||
| WoW | 170 549 | 3.4% | 4.0% | -0.1 | 20 235 891 | 3.7% | 2.8% | -0.1 | 6.2% |
| YTD | 4 323 140 | 19.7% | 3.5% | 0.1 | 506 549 578 | 22.2% | 2.6% | -0.1 | 16.6% |
| MAT | 10 603 188 | 21.2% | 3.8% | 0.4 | 1 208 501 882 | 23.3% | 2.9% | 0.2 | 7.2% |
| PROSTAMOL | |||||||||
| WoW | 26 778 | 9.4% | 19.2% | 0.4 | 37 332 056 | 8.6% | 19.9% | -0.1 | 7.0% |
| YTD | 889 548 | -5.6% | 22.2% | -3.3 | 1 251 866 449 | 6.9% | 23.3% | -4.3 | 8.3% |
| MAT | 2 087 678 | -1.6% | 24.5% | -1.6 | 2 780 631 459 | 6.9% | 25.7% | -2.5 | 4.8% |
| RESPERO MYRTOL | |||||||||
| WoW | 15 120 | -4.7% | 7.7% | 0.1 | 7 149 580 | -4.8% | 7.5% | 0.3 | -5.8% |
| YTD | 678 491 | 237.5% | 9.2% | 6.1 | 315 602 068 | 224.9% | 8.9% | 5.4 | 13.2% |
| MAT | 1 224 282 | 116.0% | 7.9% | 3.7 | 563 322 456 | 103.1% | 7.8% | 2.9 | 15.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 780 918 | 53.2% | 6.1% | 1.3 | 1 143 064 164 | 82.6% | 5.8% | 1.6 | 20.8% |
| DEXALGIN | 989 625 | 38.1% | 0.8% | 0.1 | 408 012 165 | 50.4% | 2.1% | 0.4 | 16.6% |
| ESPUMISAN (ADULTS) | 2 521 576 | 12.3% | 63.3% | -10.3 | 1 269 106 342 | 27.6% | 70.3% | -8.1 | 30.5% |
| ESPUMISAN BABY | 743 295 | -1.7% | 47.7% | -3.4 | 455 996 617 | 4.5% | 59.0% | -5.9 | 5.3% |
| FASTUM | 572 017 | -11.6% | 0.7% | -0.1 | 288 188 960 | -3.0% | 1.6% | -0.4 | 5.5% |
| IODOMARIN | 1 331 360 | 9.0% | 7.1% | 0.6 | 251 845 627 | 10.1% | 9.2% | 0.1 | -0.3% |
| LIOTON | 697 602 | -4.8% | 2.8% | -0.2 | 701 137 524 | 20.5% | 5.1% | -0.2 | 0.2% |
| MEZYM | 10 514 556 | 31.3% | 29.9% | 4 | 1 608 160 649 | 42.2% | 21.5% | 1.9 | 13.7% |
| MIG 400 | 4 323 140 | 19.7% | 3.5% | 0.1 | 506 549 578 | 22.2% | 2.6% | -0.1 | 16.6% |
| PROSTAMOL | 889 548 | -5.6% | 22.2% | -3.3 | 1 251 866 449 | 6.9% | 23.3% | -4.3 | 8.3% |
| RESPERO MYRTOL | 678 491 | 237.5% | 9.2% | 6.1 | 315 602 068 | 224.9% | 8.9% | 5.4 | 13.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 15 276 946 | 67.2% | 6.8% | 2.1 | 2 807 532 928 | 98.1% | 6.3% | 2.2 | 17.1% |
| DEXALGIN | 2 111 768 | 9.2% | 0.7% | 0 | 837 594 539 | 17.1% | 2.0% | 0.1 | 7.2% |
| ESPUMISAN (ADULTS) | 5 557 400 | 12.7% | 66.8% | -5.5 | 2 699 023 471 | 28.8% | 74.0% | -4.1 | 22.1% |
| ESPUMISAN BABY | 1 650 500 | -6.2% | 48.5% | -0.9 | 991 372 808 | 3.0% | 60.4% | -1 | -4.5% |
| FASTUM | 1 309 583 | -12.8% | 0.7% | -0.1 | 631 238 380 | -5.2% | 1.7% | -0.3 | 1.9% |
| IODOMARIN | 3 256 225 | 18.5% | 8.1% | 1.8 | 605 965 546 | 18.5% | 10.9% | 2 | -7.4% |
| LIOTON | 1 657 199 | -5.9% | 3.1% | -0.1 | 1 521 961 929 | 12.9% | 5.5% | -0.1 | -3.1% |
| MEZYM | 23 266 753 | 27.0% | 30.8% | 4.1 | 3 385 540 095 | 32.5% | 22.5% | 1.9 | 10.2% |
| MIG 400 | 10 603 188 | 21.2% | 3.8% | 0.4 | 1 208 501 882 | 23.3% | 2.9% | 0.2 | 7.2% |
| PROSTAMOL | 2 087 678 | -1.6% | 24.5% | -1.6 | 2 780 631 459 | 6.9% | 25.7% | -2.5 | 4.8% |
| RESPERO MYRTOL | 1 224 282 | 116.0% | 7.9% | 3.7 | 563 322 456 | 103.1% | 7.8% | 2.9 | 15.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 140 352 | 3.2% | 5.8% | 0.2 | 27 807 040 | 1.6% | 5.3% | 0.2 | 0.1% |
| DEXALGIN | 34 555 | -3.1% | 0.8% | -0.1 | 14 657 388 | -3.2% | 2.0% | -0.2 | 6.2% |
| ESPUMISAN (ADULTS) | 92 051 | 1.4% | 63.6% | -1.3 | 46 814 233 | 1.0% | 70.2% | -1.2 | 3.5% |
| ESPUMISAN BABY | 27 147 | -6.6% | 48.2% | -2.2 | 16 965 978 | -6.9% | 58.6% | -2.1 | -2.3% |
| FASTUM | 19 117 | 5.7% | 0.5% | 0 | 9 810 429 | 5.4% | 1.3% | 0 | 6.9% |
| IODOMARIN | 52 604 | -15.4% | 6.2% | -1.3 | 10 439 092 | -15.9% | 9.4% | -1.9 | 1.7% |
| LIOTON | 27 844 | 8.2% | 2.5% | 0 | 29 247 203 | 9.4% | 4.8% | 0.1 | 9.8% |
| MEZYM | 348 317 | 5.8% | 28.0% | -0.2 | 52 383 535 | 4.9% | 19.4% | -0.4 | 6.6% |
| MIG 400 | 170 549 | 3.4% | 4.0% | -0.1 | 20 235 891 | 3.7% | 2.8% | -0.1 | 6.2% |
| PROSTAMOL | 26 778 | 9.4% | 19.2% | 0.4 | 37 332 056 | 8.6% | 19.9% | -0.1 | 7.0% |
| RESPERO MYRTOL | 15 120 | -4.7% | 7.7% | 0.1 | 7 149 580 | -4.8% | 7.5% | 0.3 | -5.8% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 TABS TUNIC 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 TABS TUNIC 400 MG #10"
## [1] "MIG 400 TABS TUNIC 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs